Juno, Nektar Therapeutics CEOs Sold $1 Million of Stock Before Labor Day
As August came to a close and Labor Day weekend loomed, chief executives at two American biotechs each recorded stock sales of more than $1 million.
Juno Therapeutics co-founder, President and CEO Hans Edgar Bishop sold 42,673 shares on Aug. 31 for $1.28 million, or about $30 each. The transaction was conducted under a so-called Rule 10b5-1 trading plan, which has predetermined prices, amounts and dates for transactions. That same day, Bishop exercised options to acquire 18,173 shares at $6.36 each.
Juno Therapeutics co-founder, President and CEO Hans Edgar Bishop sold 42,673 shares on Aug. 31 for $1.28 million, or about $30 each. The transaction was conducted under a so-called Rule 10b5-1 trading plan, which has predetermined prices, amounts and dates for transactions. That same day, Bishop exercised options to acquire 18,173 shares at $6.36 each.